牛牛AI助理已提取核心訊息
Kevin K. Buckbee, an officer at AbbVie Inc., is set to sell 5,145 shares of the company's common stock on 02/29/2024, with an aggregate market value of $908,705.02. The shares to be sold were acquired through a mix of performance shares and retail purchases. A total of 5,099 shares were obtained as performance shares on two separate occasions, one batch on 02/28/2023 and the other on 02/28/2024. The remaining 46 shares were purchased in retail transactions spanning from 05/16/2022 to 02/15/2024. The sales notice was filed on the same day as the planned sale.
Kevin K. Buckbee, an officer at AbbVie Inc., is set to sell 5,145 shares of the company's common stock on 02/29/2024, with an aggregate market value of $908,705.02. The shares to be sold were acquired through a mix of performance shares and retail purchases. A total of 5,099 shares were obtained as performance shares on two separate occasions, one batch on 02/28/2023 and the other on 02/28/2024. The remaining 46 shares were purchased in retail transactions spanning from 05/16/2022 to 02/15/2024. The sales notice was filed on the same day as the planned sale.
艾伯維公司高管凱文·巴克比定於2024年2月29日出售該公司5,145股普通股，總市值爲908,705.02美元。待出售的股票是通過績效股票和零售購買的混合方式收購的。在兩個不同的場合共獲得了5,099股績效股票，一批於2023年2月28日，另一批於2024年2月28日。其餘46股股票是在2022年5月16日至2024年2月15日期間的零售交易中購買的。銷售通知是在計劃銷售的同一天提交的。
艾伯維公司高管凱文·巴克比定於2024年2月29日出售該公司5,145股普通股，總市值爲908,705.02美元。待出售的股票是通過績效股票和零售購買的混合方式收購的。在兩個不同的場合共獲得了5,099股績效股票，一批於2023年2月28日，另一批於2024年2月28日。其餘46股股票是在2022年5月16日至2024年2月15日期間的零售交易中購買的。銷售通知是在計劃銷售的同一天提交的。
有用
沒用